Additionally, PODXL was shown to promote astrocytoma cell survival against temozolomide-induced apoptotic stress by enhancing the activation of the PI3K/Akt survival signaling pathway. This evidence concerns the gene AKT1 and astrocytoma (excluding glioblastoma).